Effects of Clinical Pathways for Common Outpatient Infections on Antibiotic Prescribing
| Autor: | L. Miriam Dickinson, Lauren DeAlleaume, Thomas D. MacKenzie, Brian Webster, David R. West, Allison L. Sabel, Stephen E. Ross, Letoynia Coombs, Amy Irwin, Jeanne M. Rozwadowski, Timothy C. Jenkins, Connie S. Price |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Male
Drug Utilization medicine.medical_specialty medicine.drug_class Antibiotics MEDLINE Inappropriate Prescribing Article Decision Support Techniques Clinical pathway Ambulatory care Intervention (counseling) Ambulatory Care medicine Humans Antimicrobial stewardship Practice Patterns Physicians' Intensive care medicine Respiratory Tract Infections Respiratory tract infections business.industry General Medicine Anti-Bacterial Agents Practice Guidelines as Topic Emergency medicine Critical Pathways Female business |
| Zdroj: | The American Journal of Medicine. 126:327-335.e12 |
| ISSN: | 0002-9343 |
| DOI: | 10.1016/j.amjmed.2012.10.027 |
| Popis: | Antibiotic overuse in the primary care setting is common. Our objective was to evaluate the effect of a clinical pathway-based intervention on antibiotic use.Eight primary care clinics were randomized to receive clinical pathways for upper respiratory infection, acute bronchitis, acute rhinosinusitis, pharyngitis, acute otitis media, urinary tract infection, skin infections, and pneumonia and patient education materials (study group) versus no intervention (control group). Generalized linear mixed effects models were used to assess trends in antibiotic prescriptions for non-pneumonia acute respiratory infections and broad-spectrum antibiotic use for all 8 conditions during a 2-year baseline and 1-year intervention period.In the study group, antibiotic prescriptions for non-pneumonia acute respiratory infections decreased from 42.7% of cases at baseline to 37.9% during the intervention period (11.2% relative reduction) (P.0001) and from 39.8% to 38.7%, respectively, in the control group (2.8% relative reduction) (P=.25). Overall use of broad-spectrum antibiotics in the study group decreased from 26.4% to 22.6% of cases, respectively (14.4% relative reduction) (P.0001) and from 20.0% to 19.4%, respectively, in the control group (3.0% relative reduction) (P=.35). There were significant differences in the trends of prescriptions for acute respiratory infections (P.0001) and broad-spectrum antibiotic use (P=.001) between the study and control groups during the intervention period, with greater declines in the study group.This intervention was associated with declining antibiotic prescriptions for non-pneumonia acute respiratory infections and use of broad-spectrum antibiotics over the first year. Evaluation of the impact over a longer study period is warranted. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|